SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001578563-17-000011
Filing Date
2017-11-15
Accepted
2017-11-15 17:12:43
Documents
2
Period of Report
2017-11-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5650
2 POA poaeshelman.txt EX-24 3043
  Complete submission text file 0001578563-17-000011.txt   10206
Mailing Address PPD INC 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address
ESHELMAN FREDRIC N (Reporting) CIK: 0001033409 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38096 | Film No.: 171205906

Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Issuer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations